» Articles » PMID: 11844515

Mammographic Screening: No Reliable Supporting Evidence?

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2002 Feb 15
PMID 11844515
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Much confusion is being generated by the conclusion of a recent review that "there is no reliable evidence that screening for breast cancer reduces mortality." In that review, however, there was no appreciation of the appropriate mortality-related measure of screening's usefulness; and correspondingly, there was no estimation of the magnitude of this measure. We take this measure to be the proportional reduction in case-fatality rate, and studied its magnitude on the basis of the only valid and otherwise suitable trial. We found reliable evidence of fatality reduction, apparently substantial in magnitude.

Citing Articles

Mammograms and Mortality: How Has the Evidence Evolved?.

Kowalski A J Econ Perspect. 2021; 35(2):119-140.

PMID: 34421215 PMC: 8371936. DOI: 10.1257/jep.35.2.119.


The Regimen of Computed Tomography Screening for Lung Cancer: Lessons Learned Over 25 Years From the International Early Lung Cancer Action Program.

Henschke C, Yip R, Shaham D, Zulueta J, Aguayo S, Reeves A J Thorac Imaging. 2020; 36(1):6-23.

PMID: 32520848 PMC: 7771636. DOI: 10.1097/RTI.0000000000000538.


Mortality reductions due to mammography screening: Contemporary population-based data.

Hanley J, Hannigan A, OBrien K PLoS One. 2017; 12(12):e0188947.

PMID: 29261685 PMC: 5737972. DOI: 10.1371/journal.pone.0188947.


Lung cancer: Low-dose CT screening - determining the right interval.

Yankelevitz D, Henschke C Nat Rev Clin Oncol. 2016; 13(9):533-4.

PMID: 27402578 DOI: 10.1038/nrclinonc.2016.106.


The importance of the regimen of screening in maximizing the benefit and minimizing the harms.

Henschke C, Li K, Yip R, Salvatore M, Yankelevitz D Ann Transl Med. 2016; 4(8):153.

PMID: 27195271 PMC: 4860488. DOI: 10.21037/atm.2016.04.06.